Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tag: Drug development

SOP for Corrective and Preventative Actions (CAPA)

Posted on By

Protocol for Implementing CAPA in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for identifying, implementing, and verifying corrective and preventative actions (CAPA) to address non-conformities, deficiencies, and potential risks identified during Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies…

Read More “SOP for Corrective and Preventative Actions (CAPA)” »

Bioequivalence Bioavailability Study

SOP for Responding to Audit Findings

Posted on By

Protocol for Addressing Audit Observations in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for responding to audit findings and implementing corrective actions to address deficiencies identified during audits of Bioavailability (BA) and Bioequivalence (BE) study facilities in the pharmaceutical industry. Scope This SOP applies to all…

Read More “SOP for Responding to Audit Findings” »

Bioequivalence Bioavailability Study

SOP for Auditing Clinical and Bioanalytical Facilities

Posted on By

Protocol for Conducting Audits in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for conducting audits of clinical and bioanalytical facilities involved in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel involved in auditing activities, including Auditors,…

Read More “SOP for Auditing Clinical and Bioanalytical Facilities” »

Bioequivalence Bioavailability Study

SOP for Conflict of Interest Disclosure

Posted on By

Protocol for Managing Conflict of Interest in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the identification, disclosure, and management of conflicts of interest among personnel involved in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel, including…

Read More “SOP for Conflict of Interest Disclosure” »

Bioequivalence Bioavailability Study

SOP for Training of Study Personnel

Posted on By

Protocol for Study Personnel Training in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the training of personnel involved in the conduct and oversight of Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel, including Investigators, Study Coordinators,…

Read More “SOP for Training of Study Personnel” »

Bioequivalence Bioavailability Study

SOP for Regulatory Submission Preparation

Posted on By

Protocol for Compiling Regulatory Submissions for BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the preparation, compilation, and submission of regulatory documents for Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the regulatory submission process,…

Read More “SOP for Regulatory Submission Preparation” »

Bioequivalence Bioavailability Study

SOP for Final Report Preparation

Posted on By

Protocol for Generating Final Study Reports in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures and responsibilities for preparing comprehensive final reports for Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the generation, review, and approval…

Read More “SOP for Final Report Preparation” »

Bioequivalence Bioavailability Study

SOP for Archiving Study Documents

Posted on By

Protocol for Document Archiving in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the systematic archiving and retention of study documents generated during Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the conduct and oversight of…

Read More “SOP for Archiving Study Documents” »

Bioequivalence Bioavailability Study

SOP for Quality Control in Bioanalytical Labs

Posted on By

Protocol for Ensuring Quality in Bioanalytical Testing Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for maintaining quality control in bioanalytical laboratories conducting analysis for Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel involved in bioanalytical testing, including Laboratory Analysts, Quality…

Read More “SOP for Quality Control in Bioanalytical Labs” »

Bioequivalence Bioavailability Study

SOP for Quality Assurance in Study Conduct

Posted on By

Protocol for Ensuring Quality in BA/BE Study Execution Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures and responsibilities for ensuring the quality of Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the planning, execution, and oversight of…

Read More “SOP for Quality Assurance in Study Conduct” »

Bioequivalence Bioavailability Study

Posts pagination

Previous 1 2 3 4 5 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme